151 related articles for article (PubMed ID: 12774389)
21. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
22. Effects of acute, repeated and chronic variable stress on in vivo tyrosine hydroxylase activity and on alpha(2)-adrenoceptor sensitivity in the rat brain.
Prieto M; Gómez FM; Teresa Giralt M
Stress; 2003 Dec; 6(4):281-7. PubMed ID: 14660060
[TBL] [Abstract][Full Text] [Related]
23. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
Ugrumov MV; Melnikova VI; Lavrentyeva AV; Kudrin VS; Rayevsky KS
Neuroscience; 2004; 124(3):629-35. PubMed ID: 14980733
[TBL] [Abstract][Full Text] [Related]
24. Pentobarbital inhibits L-DOPA-induced dopamine increases in the rat striatum: An in vivo microdialysis study.
Adachi YU; Yamada S; Satomoto M; Watanabe K; Higuchi H; Kazama T; Doi M; Sato S
Brain Res Bull; 2006 May; 69(5):593-6. PubMed ID: 16647588
[TBL] [Abstract][Full Text] [Related]
25. Tyrosine hydroxylase activity in the locus coeruleus of conscious rats: differences with the anesthetized rats.
Robert F; Ortemann C; Seccia M; Renaud B; Lambás-Señas L
Brain Res Bull; 1994; 34(6):595-9. PubMed ID: 7922603
[TBL] [Abstract][Full Text] [Related]
26. The parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) mediates release of l-3,4-dihydroxyphenylalanine (l-DOPA) and inhibition of l-DOPA decarboxylase in the rat striatum: a microdialysis study.
Foster SB; Wrona MZ; Han J; Dryhurst G
Chem Res Toxicol; 2003 Oct; 16(10):1372-84. PubMed ID: 14565778
[TBL] [Abstract][Full Text] [Related]
27. Effects of drugs interfering with dopamine and noradrenaline biosynthesis on the endogenous 3,4-dihydroxyphenylalanine levels in rat brain.
Westerink BH; van Es TP; Spaan SJ
J Neurochem; 1982 Jul; 39(1):44-51. PubMed ID: 6123552
[TBL] [Abstract][Full Text] [Related]
28. Tetrahydrobiopterin stimulates L-DOPA release from striatal tissue.
Abreu-González P; González-Hernández T; Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; González MC
Eur J Pharmacol; 2006 Jul; 541(1-2):33-7. PubMed ID: 16750826
[TBL] [Abstract][Full Text] [Related]
29. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
Carlsson A; Kehr W; Lindqvist M
J Neural Transm; 1977; 40(2):99-113. PubMed ID: 323424
[TBL] [Abstract][Full Text] [Related]
30. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898
[TBL] [Abstract][Full Text] [Related]
31. Increased neostriatal tyrosine hydroxylation during stress: role of extracellular dopamine and excitatory amino acids.
Castro SL; Sved AF; Zigmond MJ
J Neurochem; 1996 Feb; 66(2):824-33. PubMed ID: 8592158
[TBL] [Abstract][Full Text] [Related]
32. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
Sarre S; Lanza M; Makovec F; Artusi R; Caselli G; Michotte Y
Eur J Pharmacol; 2008 Apr; 584(2-3):297-305. PubMed ID: 18342306
[TBL] [Abstract][Full Text] [Related]
33. Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
Forsback S; Niemi R; Marjamäki P; Eskola O; Bergman J; Grönroos T; Haaparanta M; Haapalinna A; Rinne J; Solin O
Synapse; 2004 Feb; 51(2):119-27. PubMed ID: 14618679
[TBL] [Abstract][Full Text] [Related]
34. Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine.
Yoshitake T; Kehr J; Yoshitake S; Fujino K; Nohta H; Yamaguchi M
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):177-83. PubMed ID: 15203027
[TBL] [Abstract][Full Text] [Related]
35. Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP.
Jin CM; Yang YJ; Huang HS; Lim SC; Kai M; Lee MK
Eur J Pharmacol; 2008 Sep; 591(1-3):88-95. PubMed ID: 18602388
[TBL] [Abstract][Full Text] [Related]
36. Endogenously released L-dopa itself tonically functions to potentiate postsynaptic D2 receptor-mediated locomotor activities of conscious rats.
Yue JL; Nakamura S; Ueda H; Misu Y
Neurosci Lett; 1994 Mar; 170(1):107-10. PubMed ID: 7913742
[TBL] [Abstract][Full Text] [Related]
37. Receptor-mediated dopaminergic function after ethanol withdrawal.
Black RF; Hoffman PL; Tabakoff B
Alcohol Clin Exp Res; 1980 Jul; 4(3):294-7. PubMed ID: 6105829
[TBL] [Abstract][Full Text] [Related]
38. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats.
Carta M; Stancampiano R; Tronci E; Collu M; Usiello A; Morelli M; Fadda F
Neuroscience; 2006; 139(4):1163-72. PubMed ID: 16530976
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Darmopil S; Muñetón-Gómez VC; de Ceballos ML; Bernson M; Moratalla R
Eur J Neurosci; 2008 Feb; 27(3):580-92. PubMed ID: 18279311
[TBL] [Abstract][Full Text] [Related]
40. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease.
Rocchitta G; Migheli R; Esposito G; Marchetti B; Desole MS; Miele E; Serra PA
J Pineal Res; 2006 Apr; 40(3):204-13. PubMed ID: 16499555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
